Novo Nordisk to file for regulatory approval of once-weekly insulin icodec next year
Trial results suggest insulin icodec has the potential to be an ideal insulin for people with type 2 diabetes, reports Novo Nordisk.
Trial results suggest insulin icodec has the potential to be an ideal insulin for people with type 2 diabetes, reports Novo Nordisk.